improvements in albumin and hemoglobin.Benefits were consistent across sex and age strata (e.g., males HR 0.68; females HR 0.59 for mortality) and were most pronounced for transplant among those without cirrhosis/HCC (HR 1.88; p<0.001). Conclusion:In this large, real-world cohort, DAA therapy was associated with substantially lower 5-year mortality and greater access to kidney transplantation, without clear differences in incident cirrhosis or liver cancer.Findings support routine, timely HCV treatment in patients with ESKD to improve survival, nutritional/hematologic status, and transplant opportunities.I have no potential conflict of interest to disclose.I used generative AI and AI-assisted technologies in the writing process.During the preparation of this work, the authors used ChatGPT (OpenAI) to assist with language refinement, organization, and clarity of expression.After using this tool, the authors carefully reviewed, revised, and edited the content, and take full responsibility for the content of the publication.
Building similarity graph...
Analyzing shared references across papers
Loading...
Saseevan et al. (Wed,) studied this question.
synapsesocial.com/papers/69c76fff8bbfbc51511e05cf — DOI: https://doi.org/10.1016/j.ekir.2026.105797
Sumana Saseevan
Dammika Mangana-Arachchi
Nadeesha Nishanthi
Vavuniya General Hospital
Kidney International Reports
University of Peradeniya
National Institute of Fundamental Studies
Vavuniya General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...